Molecular LogiX Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Molecular LogiX General Information

Description

Operator of a biotechnology company created to develop proteins that inhibit the growth of tumor cells implicated in the progression of drug-resistant tumors. The company develops Pan-HER Anti-Cancer Ligand, a genetically engineered version of the naturally occurring growth hormone that blocks the cell receptor necessary for the growth of tumor cells, providing oncologists and their patients with a new, more potent drug to treat cancer.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 6501 Fannin Street
  • Houston, TX 77030
  • United States
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Corporate Office
  • 6501 Fannin Street
  • Houston, TX 77030
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Molecular LogiX Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business 01-Dec-2018 Completed Out of Business
3. Grant 16-Mar-2007 Completed Startup
2. Seed Round $1.8M $1.8M Completed Startup
1. Accelerator/Incubator Completed Startup
To view Molecular LogiX’s complete valuation and funding history, request access »

Molecular LogiX Patents

Molecular LogiX Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2008076788-A2 Optimized pan-her ligands Inactive 15-Dec-2006
WO-2008076788-A3 Optimized pan-her ligands Inactive 15-Dec-2006
US-20080064039-A1 Designing ligand targeted drugs via amino acid modification and domain binding optimization; rational drug design Inactive 06-Jul-2006
EP-2044246-A2 Dominant negative ligand drug discovery system Inactive 06-Jul-2006
EP-2044246-A4 Dominant negative ligand drug discovery system Inactive 06-Jul-2006 G01N33/5023
To view Molecular LogiX’s complete patent history, request access »

Molecular LogiX FAQs

  • When was Molecular LogiX founded?

    Molecular LogiX was founded in 2003.

  • Where is Molecular LogiX headquartered?

    Molecular LogiX is headquartered in Houston, TX.

  • What industry is Molecular LogiX in?

    Molecular LogiX’s primary industry is Biotechnology.

  • Is Molecular LogiX a private or public company?

    Molecular LogiX is a Private company.

  • What is Molecular LogiX’s current revenue?

    The current revenue for Molecular LogiX is .

  • How much funding has Molecular LogiX raised over time?

    Molecular LogiX has raised $1.8M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process